0
Get Alert
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

1
Letter to the Editor   |    
Neuroactive Steroid Levels in Patients With Panic Disorder
BEVERLEY E. PEARSON MURPHY, M.D., Ph.D.
Am J Psychiatry 2003;160:593-594. doi:10.1176/appi.ajp.160.3.593

To the Editor: I find the article by Andreas Ströhle, M.D., et al. (1) very puzzling. The authors studied seven women and three men with panic disorder and examined them in relation to 10 age- and sex-matched comparison subjects. The steroid levels were given as the mean and SD in nanomoles per liter, with the sexes combined.

We were not told in what phase of the menstrual cycle the women were studied; one must assume, since the SDs for the steroids were relatively small—implying that the values for men and women were similar—that the women must have been studied in the follicular phase of their cycles. Or perhaps some of them were postmenopausal, since the age range was quite wide (37.2 years, SD=10.2).

However, the levels of progesterone for the comparison subjects (24.1 nmol/liter, SD=2.6), and, indeed, for all the subjects, are clearly in the luteal range!—far above the well-established value of about 1 nmol/liter in men, in postmenopausal women, and in women in the follicular phase of the cycle (24). Luteal levels range from 6 to 64 nmol/liter. The research method used was gas chromatography/mass spectrometry; one was referred to a previous article by the same group (5). In that article, the mean level of progesterone in eight healthy comparison men was 7.2 nmol/ml, while the mean level of allopregnanolone was about 4 nmol/liter. The authors’ levels of these two steroids are thus inconsistent with their own previous data.

Their progesterone values are in serious disagreement with well-established data, obtained mostly through radioimmunoassay. Their values for almost all of the steroids measured are much higher than those found by a colleague and me by using a combination of high-performance liquid chromatography and radioimmunoassay (6). While gas chromatography/mass spectrometry holds great promise for providing more sensitive methods for detection of neuroactive steroids, which are present in very low concentrations in the blood, one cannot ignore the large differences in the results obtained to date that have not been explained.

Ströhle A, Romeo E, di Michele F, Pasini A, Yassouridis A, Holsboer F, Rupprecht R: GABAA receptor-modulating neuroactive steroid composition in patients with panic disorder before and during paroxetine treatment. Am J Psychiatry  2002; 159:145-157
[PubMed]
[CrossRef]
 
Griffin JE, Wilson JD: Disorders of the testes and the male reproductive tract, in Williams Textbook of Endocrinology, 9th edition. Edited by Wilson JD, Foster DW. Philadelphia, WB Saunders, 1998, pp 819-875
 
Fisher DA, Nelson JC: Endocrine testing, in Endocrinology, 3rd edition. Edited by DeGroot LJ, Jameson JL. Philadelphia, WB Saunders, 2001, p 2594
 
Laposata M: The New England Journal of Medicine SI Unit Conversion Guide. Boston, NEJM Books, 1992, p 43
 
Romeo E, Ströhle A, Spalletta G, di Michele F, Hermann B, Holsboer F, Pasini A, Rupprecht R: Effects of antidepressant treatment on neuroactive steroids in major depression. Am J Psychiatry  1998; 155:910-913
[PubMed]
 
Pearson Murphy BE, Allison CM: Determination of progesterone and some of its neuroactive ring A-reduced metabolites in human serum. J Steroid Biochem Mol Biol  2000; 74:134-142
 
+

References

Ströhle A, Romeo E, di Michele F, Pasini A, Yassouridis A, Holsboer F, Rupprecht R: GABAA receptor-modulating neuroactive steroid composition in patients with panic disorder before and during paroxetine treatment. Am J Psychiatry  2002; 159:145-157
[PubMed]
[CrossRef]
 
Griffin JE, Wilson JD: Disorders of the testes and the male reproductive tract, in Williams Textbook of Endocrinology, 9th edition. Edited by Wilson JD, Foster DW. Philadelphia, WB Saunders, 1998, pp 819-875
 
Fisher DA, Nelson JC: Endocrine testing, in Endocrinology, 3rd edition. Edited by DeGroot LJ, Jameson JL. Philadelphia, WB Saunders, 2001, p 2594
 
Laposata M: The New England Journal of Medicine SI Unit Conversion Guide. Boston, NEJM Books, 1992, p 43
 
Romeo E, Ströhle A, Spalletta G, di Michele F, Hermann B, Holsboer F, Pasini A, Rupprecht R: Effects of antidepressant treatment on neuroactive steroids in major depression. Am J Psychiatry  1998; 155:910-913
[PubMed]
 
Pearson Murphy BE, Allison CM: Determination of progesterone and some of its neuroactive ring A-reduced metabolites in human serum. J Steroid Biochem Mol Biol  2000; 74:134-142
 
+
+

CME Activity

There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
Submit a Comments
Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of APA editorial staff.

* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe



Related Content
Books
The American Psychiatric Publishing Textbook of Psychopharmacology, 4th Edition > Chapter 47.  >
The American Psychiatric Publishing Textbook of Psychopharmacology, 4th Edition > Chapter 47.  >
The American Psychiatric Publishing Textbook of Psychopharmacology, 4th Edition > Chapter 47.  >
The American Psychiatric Publishing Textbook of Psychopharmacology, 4th Edition > Chapter 62.  >
The American Psychiatric Publishing Textbook of Psychopharmacology, 4th Edition > Chapter 62.  >
Topic Collections
Psychiatric News
APA Guidelines
PubMed Articles